ArticleFrontiers in immunology2023

Safety and feasibility of toripalimab plus lenvatinib with or without radiotherapy in advanced BTC.

Yunchao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.